The estimated Net Worth of Peter Virsik is at least $756 Thousand dollars as of 9 September 2024. Mr Virsik owns over 694 units of Essa Pharma Inc stock worth over $59,798 and over the last 4 years he sold EPIX stock worth over $48,994. In addition, he makes $646,753 as Exec. VP & COO at Essa Pharma Inc.
Mr has made over 9 trades of the Essa Pharma Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he sold 694 units of EPIX stock worth $4,164 on 9 September 2024.
The largest trade he's ever made was exercising 72,782 units of Essa Pharma Inc stock on 6 February 2024 worth over $235,086. On average, Mr trades about 6,771 units every 21 days since 2020. As of 9 September 2024 he still owns at least 8,470 units of Essa Pharma Inc stock.
You can see the complete history of Mr Virsik stock trades at the bottom of the page.
Peter A. Virsik M.B.A., M.S. is the Exec. VP & COO at Essa Pharma Inc.
As the Exec. VP & COO of Essa Pharma Inc, the total compensation of Mr S at Essa Pharma Inc is $646,753. There are 1 executives at Essa Pharma Inc getting paid more, with Dr. David Ross Parkinson M.D. having the highest compensation of $829,556.
Mr S is 50, he's been the Exec. VP & COO of Essa Pharma Inc since . There are 2 older and no younger executives at Essa Pharma Inc. The oldest executive at Essa Pharma Inc is Dr. David Ross Parkinson M.D., 71, who is the Pres, CEO & Director.
Peter's mailing address filed with the SEC is C/O ESSA PHARMA INC., 999 WEST BROADWAY, SUITE 720, VANCOUVER, A1, V5Z 1K5.
Over the last 4 years, insiders at Essa Pharma Inc have traded over $924,311 worth of Essa Pharma Inc stock and bought 3,342,445 units worth $15,321,880 . The most active insiders traders include Growth N Vbb Biotech Ag Bio..., Franklin M Berger, and Marella Thorell. On average, Essa Pharma Inc executives and independent directors trade stock every 57 days with the average trade being worth of $1,108,300. The most recent stock trade was executed by Peter Virsik on 9 September 2024, trading 694 units of EPIX stock currently worth $4,164.
as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company.
Essa Pharma Inc executives and other stock owners filed with the SEC include: